Showing results (851-860 of 3,350) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|July 17, 2022
China Health Related Outcomes Measures (CHROME): Development of a New Generic Preference-Based Measure for the Chinese PopulationJing Wu, Xiaoning He, Pinan Chen, et al.Pharmacoeconomics|September 27, 2019
Assessment-Schedule Matching in Unanchored Indirect Treatment Comparisons of Progression-Free Survival in Cancer StudiesVenediktos Kapetanakis, Thibaud Prawitz, Michael Schlichting, et al.Pharmacoeconomics|March 14, 2019
Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer PatientsMichelle Tew, Philip Clarke, Karin Thursky, et al.Pharmacoeconomics|October 2, 2019
Economic Implications of Hepatocellular Carcinoma Surveillance and Treatment: A Guide for CliniciansAlisa Likhitsup, Neehar D ParikhPharmacoeconomics|March 6, 2019
Correction to: The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case StudyJosé Leal, Stefania Manetti, James BuchananPharmacoeconomics|February 8, 2021
Global Economic Burden of Attention-Deficit/Hyperactivity Disorder: A Systematic ReviewAnindit Chhibber, Alexandre Hikiji Watanabe, Chayutthaphong Chaisai, et al.Pharmacoeconomics|February 18, 2017
Pharmacy Benefit Management Companies: Do They Create Value in the US Healthcare System?Alan LylesPharmacoeconomics|January 27, 2005
Follow-up lipid tests and physician visits are associated with improved adherence to statin therapyJoshua S Benner, Jonothan C Tierce, Christie M Ballantyne, et al.Pharmacoeconomics|January 22, 2005
The economics of follow-on drug research and development: trends in entry rates and the timing of developmentJoseph A DiMasi, Cherie PaquettePharmacoeconomics|January 22, 2005
Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressuresHenry GrabowskiPageof 335